In­tel­lia and Iver­ic sell stocks to raise mon­ey, each net­ting $300M

Wednes­day af­ter­noon, Gene edit­ing com­pa­ny In­tel­lia and eye dis­ease com­pa­ny Iver­ic Bio an­nounced that they had each raised $300 mil­lion by sell­ing off some of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER